Activity value 90israel Buyer&Supplier,Last transaction date:
2026-02-25Address: 1 cottesbrooke park, heartlands business park, daventry, northamptonshire, nn11 8yl, uk
Overview
Contact
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for dexcel pharma ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 6 transactions, with a transaction quantity of 3040.7 and a transaction weight of 0.
YearTransactionsQuantityWeight
20253829808.310
202663040.70
Bill of lading data
<
1/15
>
Trade date
2026/02/25
B/L No.
6732785
Suppliers
centrient pharmaceuticals india pvt.ltd.
Buyers
dexcel pharma ltd.
dexcel pharma ltd. is israel Buyer&Supplier,
and primarily engages in the import and export business of products such as omeprazole usp,nintedanib,foreign exchange.
According to the 52wmb.com global trade database, as of 2026-02-25, the company has completed 2066 international trades,
with its main trading regions covering india,canada,other etc.
The core products include HS29333929,HS29333990,HS33049900 etc,
often transported via hamburg,port haifa, port tel aviv yafo etc,
and its main trading partners are indoco remedies ltd.,cadila healthcare ltd.,berry plastics canada inc..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on dexcel pharma ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.